Sign in

CIK 0001812364

  • Large accelerated filer

Relay Therapeutics, Inc.

Sign in to watch
Ticker
RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-370-8837
Business address
60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
  1. 4 Open-market sale Chief Administrative Officer sold 265 shares at $20.31 ($5,382)
  2. 4 Open-market sale Chief Financial Officer sold 300 shares at $20.31 ($6,093)
  3. 4 Open-market sale Chief Legal Officer sold 300 shares at $20.31 ($6,093)
  4. 4 Open-market sale President, R&D sold 8,999 shares at an average $20.03 ($180,290)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market sale President, R&D sold 14,811 shares at an average $24.74 ($366,367)
  12. 4 Open-market sale Chief Administrative Officer sold 435 shares at $25.57 ($11,123)
  13. 4 Open-market sale Chief Financial Officer sold 725 shares at $25.57 ($18,538)
  14. 4 Open-market sale Chief Legal Officer sold 708 shares at $25.57 ($18,104)
  15. 4 Open-market sale President and CEO sold 84,000 shares at an average $31.42 ($2,639,280)
  16. 4 Open-market sale President, R&D sold 18,000 shares at $30.32 ($545,760)
  17. 4 Open-market sale Chief Administrative Officer sold 294 shares at $29.87 ($8,782)
  18. 4 Open-market sale Chief Financial Officer sold 282 shares at $29.87 ($8,423)
  19. 4 Open-market sale President, R&D sold 622 shares at $29.87 ($18,579)
  20. 4 Open-market sale Chief Legal Officer sold 333 shares at $29.87 ($9,947)

Page 12 of 16 · 320 filings